Economic Analysis of Community Pharmacy

Award

Buyers

Value

£500,000

Classifications

  • Health services

Tags

  • award

Submission Deadline

2 years ago

Published

1 year ago

Description

NHS England's vision is for the community pharmacy sector to play an increased role in the delivery of integrated primary care services to support access challenges in primary care. We expect this will help to release capacity in the wider NHS to address more acute and complex health conditions. This will help deliver the vision of integrated primary care set out by Fuller Stocktake Report.

Community pharmacists and pharmacy technicians could further strengthen NHS primary care by offering a wider range of clinical, and prescribing services for improving individual, and population health. This will in part offer patient convenience and choice, as well as serve to relieve problems with accessing GP practices, and A&E departments.

This economic analysis will provide NHSE with the information required to make effective commissioning decisions for the future community pharmacy sector, and will provide a robust, and detailed evidence base for any bids for funding from central Government.

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete